Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
24.0%
% of BBH's 27 holdings also in IDNA
13.3%
% of IDNA's 49 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 10.9% | 5.9% | 5.9% |
|
REGENERON PHARMACEUTICALS | 6.5% | 3.1% | 3.1% |
 |
BIONTECH SE SPONSORED ADR | 2.7% | 5.0% | 2.7% |
|
SAREPTA THERAPEUTICS INC | 2.0% | 4.2% | 2.0% |
|
INCYTE CORP | 1.6% | 4.9% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to IDNA
|
AMGEN INC | 15.3% |
|
VERTEX PHARMACEUTICALS INC | 10.8% |
 |
ARGENX SE ADR | 5.6% |
|
GILEAD SCIENCES INC | 4.9% |
|
IQVIA HOLDINGS INC | 4.6% |
|
ILLUMINA INC | 4.4% |
|
NATERA INC | 4.0% |
|
BIOGEN IDEC INC | 3.6% |
 |
ICON PLC | 3.5% |
|
REGENERON PHARMACEUTICALS | 3.4% |
BBH Underweight Relative to IDNA
|
EXELIXIS INC | -6.7% |
 |
BEIGENE, LTD. | -4.8% |
|
REVOLUTION MEDICINES, INC. | -4.7% |
 |
ROCHE HOLDING LTD | -4.4% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.2% |
 |
SANOFI-AVENTIS | -4.0% |
|
ARCELLX, INC. | -3.9% |
 |
GSK PLC | -3.4% |
|
INCYTE CORP | -3.3% |
|
MERCK & CO. INC. | -3.3% |